Penn Capital Management Company, LLC Travere Therapeutics, Inc. Transaction History
Penn Capital Management Company, LLC
- $914 Million
- Q1 2025
A detailed history of Penn Capital Management Company, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Penn Capital Management Company, LLC holds 21,094 shares of TVTX stock, worth $451,622. This represents 0.04% of its overall portfolio holdings.
Number of Shares
21,094Holding current value
$451,622% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
227Shares Held
96.3MCall Options Held
1.54MPut Options Held
599K-
Black Rock Inc. New York, NY7.64MShares$164 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.36MShares$158 Million1.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.01MShares$107 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.97MShares$106 Million3.46% of portfolio
-
Macquarie Group LTD Australia, C34.26MShares$91.2 Million0.09% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.37B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...